Bio-Works Technologies AB, 556935-3559 - På krafman.se hittar du, gratis årsredovisning, kreditupplysning, företagsinformation för Bio-Works Technologies

Bio-Works proprietary agarose bead technology allows use of smaller beads, giving faster mass transport. Surface properties are also favorable for purifying hydrophobic proteins and peptides. Higher. WorkBeads cross-linking gives more ‘walls’ in the beads and greater accessible surface area both for ligand coupling and target molecules.

Kunderna återfinns främst inom den europeiska marknaden där produkterna säljs via olika distributionspartners och vidare till bolag inom Bio-Works Technologies AB har 3 anställda och gjorde ett resultat på -39 797 KSEK med omsättning 5 849 KSEK under 2019. Bolaget hade då en omsättningstillväxt på 45,9 %. Bio-Works Technologies vinstmarginal låg vid senaste årsbokslutet på -680,4 % vilket ger Bio-Works Technologies placeringen 399 358 i Sverige av totalt 651 366 aktiebolag. Bio-Works Technologies | 2 106 följare på LinkedIn. Purification made simple | Bio-Works was founded in 2006 and is involved in R&D, manufacturing and supply of innovative, leading edge products used to separate proteins and other biomolecules.

Purification made simple | Bio-Works was founded in 2006 and is involved in R&D, manufacturing and supply of innovative, leading edge products used to separate proteins and other biomolecules. Our staff is rich in experience within the Swedish Life science industry and are specialized in resins for separation and purification. Bio-Works Bio-Works Technologies utvecklar produkter som separerar och renar molekyler vid framställning av nya läkemedel. Teknologin baseras på kromatografi som har som avsikt att förbättra läkemedelssubstansen och tillföra kroppen renare läkemedel. Bio-Works Technologies AB har 3 anställda och gjorde ett resultat på -39 797 KSEK med omsättning 5 849 KSEK under 2019. Bolaget hade då en omsättningstillväxt på 45,9 %.

Teknologin baseras på kromatografi som har som avsikt att förbättra läkemedelssubstansen och tillföra kroppen renare läkemedel. Bio-Works Technologies ligger i en stigande trendk This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title.

Bio-Works signs licensing agreement with Amicogen.. February 17, 2021. Bio-Works Technologies AB has signed a licensing agreement with Amicogen Inc to establish local production of agarose resins

We unify nature and science to reinvent the way food is grown and water is treated. 3:30 Find the latest Bio-Works Technologies AB (BIOWKS.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.

Bio-Works was founded in 2006 and is involved in R&D, manufacturing and supply of innovative, leading edge products used to separate proteins and other biomolecules. Our staff is rich in experience

February 17, 2021. Bio-Works Technologies AB has signed a licensing agreement with Amicogen Inc to establish local production of agarose resins in South Korea The.. But as Bio-Works Technologies. has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data. Show section Bio-Works signs licensing agreement with Amicogen.. February 17, 2021. Bio-Works Technologies AB has signed a licensing agreement with Amicogen Inc to establish local production of agarose resins Bio-Works carries out R&D, manufacturing and supply of agarose-based resins used to separate proteins and other biomolecules.

På Bolagsfakta.se hittar du kontakt-och företagsinformation, nyckeltal, lön till VD & styrelse m.m..
Vad är ett registerutdrag

The latest Bio-Works Technologies AB NPV share price. View recent trades and share price information for Bio-Works Technologies AB NPV. View today's stock price, news and analysis for Bio-Works Technologies AB ( BIOWKS).

Note that the company may have other share series admitted to trading and that it may have unlisted shares.
Damp test

sociala förmåner betyder
löneväxling efter 65 år
erik nording pipes
pokemom go
japansk forfatter nobelpris
hasselgrens royal design

View today's stock price, news and analysis for Bio-Works Technologies AB ( BIOWKS). Barron's also provides information on historical stock ratings, target

Bolaget hade då en omsättningstillväxt på 45,9 %. Bio-Works Technologies vinstmarginal låg vid senaste årsbokslutet på -680,4 % vilket ger Bio-Works Technologies placeringen 399 358 i Sverige av totalt 651 366 aktiebolag.

Kateterisering kvinna film
episk lyrisk

2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares.

2021-04-19 Bio-Works Technologies AB: Bokslutskommuniké januari-december 2020. Nettoomsättningen ökade med nästan 4% till 3 541 (3 414) KSEK med god tillväxt i Europa och Asien. Orderingången ökade med nästan 3% till 3 201 (3 117) KSEK. Resultatet andra halvåret var -23 887 (-20 587) KSEK. Bio-Works Technologies har erhållit en order värd 1,3 miljoner kronor från PolyPeptide Laboratories Inc i USA. Beställningen avser ett nytt projekt hos kontrakttillverkaren och omfattas av en "Health Resources Priorities and Allocations System (HRPAS) Rating" via amerikanska statens Operation Warp Speed.Jonathan Royce, VD på Bio-Works: Bio-Works Technologies AB (publ), Virdings allé 18, 754 50 Uppsala, Sweden Tel: +46 8 562 674 30, Fax +46 8 124 513 29, E-mail: info@bio-works.com This information is such that Bio-Works Technologies AB (publ) is obliged to publish in accordance with the EU Market Abuse Regulation. This information was provided by the persons named above for Bio-Works Technologies.